BioSpace News Archive

ATIXA has, at times, issued position statements when it sees an unhealthy direction in the field in the hope that its position can offer some level of correction.

AmerisourceBergen, a global healthcare solutions leader, is expanding access to its Opioid Assistance Pilot Program to all full-time associates and their dependents in Texas, South Carolina, North Carolina, and Pennsylvania who are enrolled in a company-sponsored medical plan.

Patients, Whether Insured or Not, Can Pay Less Than $50 to Purchase an Over-the-Counter Telemedicine Visit to Receive Treatment in Under 30 Minutes

Neovasc announced that it has received written notification from The Nasdaq Stock Market LLC notifying the Company that it is not in compliance with the minimum market value requirement set forth in Nasdaq Rules for continued listing on the Nasdaq Capital Market.

CNO Financial Group and Bankers Life, the national life and health insurer, announced that it is supporting the Alzheimer’s Association with $369,000 for Alzheimer’s care, education and research programs.

Second quarter revenue of $17.6 million, an increase of 21% from $14.6 million in the first quarter of 2019

Sorafenib is a first-line therapy that is FDA-approved for treating inoperable hepatocellular carcinoma

Medical Marijuana, Inc. (“the Company”) (OTC: MJNA), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, today announced that equity research firm Avise Analytics, Ltd. (“Avise Analytics”) ranked the Company as one of the Top 5 Companies in the Hemp-Based Cannabidiol (CBD) Market.

Clinical use continues to increase with more than 20% annual growth in processed units.1

Set to present at two healthcare equity conferences in early September.